Diabetes and obesity

• Development and possibilities of contemporary outpatient diabetology: editorial
• Meformin and predictive biomarkers in the broad spectrum of internal diseases
• Steroid (glucocorticoids) induced hyperglycemia and diabetes
• Where do we stand in controlling dyslipidemia in patients with type 2 diabetes mellitus? Retrospective analysis 2019–2023

Table of contents